JP2015140338A - Anti-aging related gene expression promoter - Google Patents
Anti-aging related gene expression promoter Download PDFInfo
- Publication number
- JP2015140338A JP2015140338A JP2014015776A JP2014015776A JP2015140338A JP 2015140338 A JP2015140338 A JP 2015140338A JP 2014015776 A JP2014015776 A JP 2014015776A JP 2014015776 A JP2014015776 A JP 2014015776A JP 2015140338 A JP2015140338 A JP 2015140338A
- Authority
- JP
- Japan
- Prior art keywords
- products
- sod
- aging
- vulgare
- gene expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 36
- 230000003712 anti-aging effect Effects 0.000 title abstract description 17
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 34
- 230000032683 aging Effects 0.000 claims abstract description 13
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 8
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 5
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 5
- 229940032362 superoxide dismutase Drugs 0.000 claims abstract description 5
- 101150017120 sod gene Proteins 0.000 claims description 38
- 239000004480 active ingredient Substances 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 9
- 235000020934 caloric restriction Nutrition 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 6
- 238000013459 approach Methods 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 244000199081 Hordeum vulgare f. hexastichon Species 0.000 abstract 1
- 235000021581 juice product Nutrition 0.000 abstract 1
- 241000209219 Hordeum Species 0.000 description 30
- 239000002609 medium Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241000244206 Nematoda Species 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 238000010195 expression analysis Methods 0.000 description 5
- 230000036542 oxidative stress Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 description 4
- 102000008221 Superoxide Dismutase-1 Human genes 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000020827 calorie restriction Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 108010045815 superoxide dismutase 2 Proteins 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000282560 Macaca mulatta Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910021654 trace metal Inorganic materials 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229940122029 DNA synthesis inhibitor Drugs 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001167795 Escherichia coli OP50 Species 0.000 description 1
- 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000836222 Homo sapiens Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 208000028922 artery disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
Description
本発明は、大麦若葉を有効成分とする抗老化関連遺伝子であるスーパ−オキサイドディスムターゼ(活性酸素消去酵素;以下SODと略す)の遺伝子発現促進剤に関する。 The present invention relates to a gene expression promoter for super-oxide dismutase (reactive oxygen scavenging enzyme; hereinafter abbreviated as SOD), which is an anti-aging related gene containing young barley leaves as an active ingredient.
現在、先進諸国では、寿命の延長が顕著である。なかでも我が国は世界有数の長寿国である。しかし近年、運動量の減少やストレスの増加、食事の欧米化によるカロリーの過剰摂取、栄養バランスの欠如等により健康寿命の延長には至っていない。 At present, the extension of lifespan is remarkable in developed countries. In particular, Japan is one of the world's leading longevity countries. However, in recent years, the healthy life expectancy has not been extended due to a decrease in exercise amount, an increase in stress, an excessive intake of calories due to westernization of meals, a lack of nutritional balance, and the like.
健康寿命の延長には抗老化が必要となっている。抗老化、換言すれば寿命を延長させる一つの手段として、カロリー制限が挙げられている。カロリー制限は、酵母、線虫、げっ歯類という幅広い生物種に対して寿命延長モデルとして確立している。さらに、アカゲザルを使ったカロリー制限に関する実験により、霊長類の新陳代謝に変化を及ぼし延命効果を高めるという、有力な証拠が提示されている(非特許文献1)。 Anti-aging is necessary to extend healthy life expectancy. Caloric restriction is cited as one means of anti-aging, in other words, extending the lifespan. Caloric restriction has been established as a life extension model for a wide range of species such as yeast, nematodes, and rodents. In addition, experiments on caloric restriction using rhesus monkeys have shown promising evidence that changes in primate metabolism and enhances the life-prolonging effect (Non-patent Document 1).
また、生体の酸化反応と抗酸化反応のバランスが前者に傾いた酸化ストレスの状態においては、老化、癌、生活習慣病の病態に酸化ストレスが関与していることが明らかとなってきている(非特許文献2)。 Moreover, in the state of oxidative stress in which the balance between the oxidative reaction and the antioxidant reaction in the living body is leaning toward the former, it has become clear that oxidative stress is involved in the pathogenesis of aging, cancer, and lifestyle-related diseases ( Non-patent document 2).
この老化の原因の1つとされる酸化ストレスの影響を受けにくくすることにより寿命が延長されると考えられる。食餌を制限すると、転写因子PHA−4のmRNA量の増加と共にSODをコードする幾つかの遺伝子の発現も上昇する(非特許文献3、4)。即ち、食餌制限により酸化ストレスの影響を受けにくくなると考えられる。遺伝子組換えによりSODを過剰発現させることにより寿命が延長することが報告されていることからも(非特許文献5)、酸化ストレスの低減は抗老化に有効、即ち、細胞内のSOD遺伝子発現量を上昇させることにより寿命の延長を見込むことができると考えられる。 It is thought that the lifetime is extended by making it less susceptible to the oxidative stress that is one of the causes of this aging. When the diet is restricted, the expression of several genes encoding SOD increases with an increase in the amount of mRNA of the transcription factor PHA-4 (Non-patent Documents 3 and 4). That is, it is considered that the dietary restriction makes it less susceptible to oxidative stress. Since it has been reported that the life span is extended by overexpression of SOD by gene recombination (Non-patent Document 5), reduction of oxidative stress is effective for anti-aging, that is, the amount of SOD gene expression in cells. It is thought that extending the life can be expected by raising
カロリー制限による寿命延長効果は、ヒトにも一定の効果があると考えられる。しかしながら、カロリー制限は、精神的ストレスを増加し、感染に対する抵抗性を低下させる可能性が考えられ、管理された条件下におけるアカゲザルでの結果がそのままヒトに当てはまらない可能性がある。従って、カロリー制限に替わる新たな抗老化法の開発が求められている。 The life extension effect by calorie restriction is considered to have a certain effect on humans. However, caloric restriction may increase mental stress and reduce resistance to infection, and the results in rhesus monkeys under controlled conditions may not apply directly to humans. Accordingly, there is a need for the development of a new anti-aging method that replaces calorie restriction.
また、抗老化物質をスクリーニングする方法としては、線虫(Caenorhabditis elegans、以下C.elegansとする)を用いた寿命測定試験や、各種動物の老化関連遺伝子の発現量解析が挙げられる。C.elegansは老化研究に適したモデル動物として広く知られている。その老化プロセスは遺伝子レベルでも研究が進められ、ヒトを始めとする哺乳類の老化研究をはじめ欠かせないモデル系である(非特許文献6)。その平均寿命は遺伝的に制御され一定(20℃でおよそ20日)である上、加齢と共に細胞内及び組織の代謝活性が低下し、過酸化物が蓄積するなど高等動物と同様のプロセスを経て死に至る。即ち、C.elegansの寿命は細胞及び組織の老化の指標といえる。これらのことは、C.elegansの寿命を延ばすことが老化を抑制することに他ならないことを意味する。 Examples of methods for screening anti-aging substances include life-time measurement tests using nematodes (Caenorhabditis elegans, hereinafter referred to as C. elegans) and analysis of expression levels of aging-related genes in various animals. C. elegans is widely known as a model animal suitable for aging research. The aging process has been studied at the gene level, and is an indispensable model system for aging studies of mammals including humans (Non-Patent Document 6). Its life span is genetically controlled and constant (approximately 20 days at 20 ° C.), and the metabolic activity of cells and tissues decreases with age, and peroxides accumulate. After death. That is, the life span of C. elegans can be said to be an indicator of cell and tissue aging. These means that prolonging the lifespan of C. elegans is nothing other than inhibiting aging.
老化関連遺伝子と考えられているSOD遺伝子発現量を測定する場合は、一般的な定量RT−PCR法を用いることができる。SODは、活性酸素の1種であるスーパーオキシド(・O2 −)を消去する酵素として知られており、なかでも、SODは、ミトコンドリア等で発生する活性酸素を除去する酵素である。SODは、運動により活性化され、SODを活性化することにより、心臓動脈の疾患による病気や死の可能性を減らすことも報告されている(非特許文献7)。 When measuring the expression level of the SOD gene, which is considered to be an aging-related gene, a general quantitative RT-PCR method can be used. SOD is known as an enzyme that eliminates superoxide (.O 2 − ), which is one type of active oxygen, and SOD is an enzyme that removes active oxygen generated in mitochondria and the like. It has also been reported that SOD is activated by exercise, and by activating SOD, the possibility of illness and death due to cardiac artery disease is reduced (Non-patent Document 7).
SOD発現量を上昇させる素材として、アントシアニン含有馬鈴薯由来のアントシアニン含有物(特許文献1)や、リンゴ、ナシに含まれるフラボノイドであるフロレチン、プロポリスや薬用植物エキスに含まれるフラボノイドであるガランギン(特許文献2)が報告されている。 As materials for increasing the SOD expression level, anthocyanin-containing potato-derived anthocyanin-containing materials (Patent Document 1), flavonoids contained in apples and pears, phloretin, flavonoids contained in propolis and medicinal plant extracts (Patent Documents) 2) has been reported.
他方、大麦若葉は、食物繊維、カリウム、カルシウム、マグネシウム、亜鉛、鉄、銅などのミネラル、ビタミンB1、ビタミンC、カロチンなどのビタミンといった栄養分が多く含まれることが知られ、腸内環境の改善、コレステロールの吸収抑制、食後の血糖値の急上昇防止作用があるとされ、健康食品の素材として利用されている(特許文献3)。その他、大麦若葉から抽出されたペンタペプチドを含有する血小板凝集阻止剤が知られている(特許文献4)。 On the other hand, barley young leaves are known to contain a lot of nutrients such as dietary fiber, minerals such as potassium, calcium, magnesium, zinc, iron, copper, vitamins such as vitamin B1, vitamin C, carotene, etc., improving the intestinal environment It is said that it has the effect of inhibiting absorption of cholesterol and preventing a rapid increase in blood sugar level after meals, and is used as a material for health foods (Patent Document 3). In addition, a platelet aggregation inhibitor containing a pentapeptide extracted from barley young leaves is known (Patent Document 4).
SODを経口摂取しても胃酸などにより分解されてしまうと考えられることから、SODそのものを経口摂取するのではなく、体内のSOD発現量を上昇させ、ヒトが本来持っているSOD活性を上昇させることが求められている。本発明の課題は、カロリー制限とは異なる手法による新たな抗老化アプローチとして、摂取して安全な寿命延長又は老化防止の作用を有するSOD遺伝子発現促進剤を提供することにある。 Since it is considered that even when SOD is ingested orally, it is decomposed by gastric acid or the like, rather than ingesting SOD itself, the amount of SOD expression in the body is increased and the SOD activity inherent in humans is increased. It is demanded. The subject of this invention is providing the SOD gene expression promoter which has the effect | action of a life extension or anti-aging which is safe to ingest as a new anti-aging approach by the method different from calorie restriction.
本発明者らは、抗老化関連遺伝子であるSODの遺伝子発現量を解析することは、カロリー制限と同様の抗老化効果をもつ物質のスクリーニングに非常に有効であると考え、天然の食品素材を標的としたスクリーニングを行い、大麦若葉の搾汁が抗老化関連遺伝子であるSOD遺伝子の発現を促進させ、抗老化作用を有することを見いだし、本発明を完成するに至った。 The present inventors consider that analyzing the gene expression level of SOD, which is an anti-aging related gene, is very effective for screening a substance having an anti-aging effect similar to caloric restriction. The target screening was performed, and it was found that the squeezed barley leaf juice promotes the expression of the SOD gene, which is an anti-aging-related gene, and has an anti-aging effect, thereby completing the present invention.
すなわち、本発明は、大麦若葉を有効成分として含有することを特徴とするSODの遺伝子発現促進剤や、かかるSODの遺伝子発現促進剤を含むことを特徴とする寿命延長又は老化防止のためのサプリメントに関する。 That is, the present invention relates to a SOD gene expression promoter characterized by containing young barley leaves as an active ingredient, and a supplement for life extension or prevention of aging, characterized by comprising such a SOD gene expression promoter. About.
本発明によると、摂取して安全かつ有効な、抗老化関連遺伝子であるSODの遺伝子発現促進剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the gene expression promoter of SOD which is an anti-aging related gene which can be ingested safely and effectively can be provided.
本発明のSODの遺伝子発現促進剤としては、大麦若葉を有効成分として含有するものであれば特に制限されるものではなく、SODの種類としては、ヒトを含む哺乳類で存在が知られているSOD1、SOD2、SOD3等を挙げることができる。また、本発明のSODの遺伝子発現促進とは、SOD遺伝子のmRNAへの転写促進、mRNAの翻訳促進等によるSODの発現量を上昇させることをいう。 The SOD gene expression promoter of the present invention is not particularly limited as long as it contains barley young leaves as an active ingredient, and the type of SOD is known to exist in mammals including humans. , SOD2, and SOD3. Further, the promotion of SOD gene expression of the present invention means to increase the expression level of SOD by promoting transcription of SOD gene into mRNA, promoting translation of mRNA, and the like.
本発明における大麦若葉としては、二条大麦、四条大麦、六条大麦、裸大麦等のHordeum vulgare種に属する大麦の、穂が実る前の背丈が20〜40cm程度に成長した若葉そのものやその処理物、例えば、大麦若葉の搾汁処理物、粉砕処理物、細断処理物、乾燥処理物、焙煎処理物、抽出処理物、粉末化処理物、凍結処理物の他、搾汁・乾燥粉末化処理物、細断・乾燥処理物、粉砕・濾過処理物(ピューレ、ジュース)、細断・熱湯抽出処理物等のこれらの組み合わせ処理物を挙げることができる。例えば、大麦若葉の搾汁粉末は、大麦若葉を刈り取り、圧搾により搾り出した液をスプレードライにより乾燥することにより調製することができる。この搾汁粉末は、そのままで、あるいは他の賦形剤等を配合して、本発明のSODの遺伝子発現促進剤として好適に利用できる。 As barley young leaves in the present invention, barley belonging to the Hordeum vulgare species such as Nijo barley, Shijo barley, Rojo barley, and bare barley, the young leaves themselves that have grown to a height of about 20 to 40 cm before the ears grow, and processed products thereof, For example, barley young leaves squeezed processed products, pulverized processed products, shredded processed products, dried processed products, roasted processed products, extracted processed products, powdered processed products, frozen processed products, squeezed and dried powdered processing Examples of these products include processed products, shredded / dried products, pulverized / filtered products (pure, juice), shredded / hot water extraction processed products, and the like. For example, barley young leaf squeezed powder can be prepared by cutting barley young leaves and drying the liquid squeezed by squeezing by spray drying. This squeezed powder can be suitably used as the SOD gene expression promoter of the present invention as it is or with other excipients.
本発明のSODの遺伝子発現促進剤は、寿命延長又は老化防止のための、予防・治療剤やサプリメントや食品添加物や飼料添加物として用いることができる。ここで、寿命延長とは、ヒトを含む動物の寿命を延ばすことをいい、また老化防止とは、ヒトを含む動物の身体的能力の低下、身体の機能の低下など身体に現れる老化現象を防止することをいう。かかる寿命延長又は老化防止効果は、大麦若葉を有効成分とするSODの遺伝子発現促進剤が、SOD遺伝子のmRNAへの転写促進、mRNAの翻訳促進等によるSODの発現量を上昇させることにより、老化の原因であるスーパーオキシドの除去がさかんに行われることで奏される。 The SOD gene expression promoter of the present invention can be used as a prophylactic / therapeutic agent, supplement, food additive, or feed additive for life extension or prevention of aging. Here, life extension refers to extending the life of animals including humans, and aging prevention refers to preventing aging phenomena that appear in the body, such as a decrease in the physical abilities of humans, including humans, and a decrease in body functions. To do. Such a life extension or anti-aging effect can be achieved by an SOD gene expression promoter comprising young barley leaves as an active ingredient by increasing the SOD expression level by promoting transcription of the SOD gene into mRNA, promoting translation of mRNA, etc. This is achieved by removing superoxide, which is the cause of
本発明のSOD遺伝子の発現促進剤や、上記予防・治療剤、サプリメント、食品添加物、又は飼料添加物の剤型としては、粉剤、錠剤、カプセル剤、顆粒剤、散剤、液剤などを挙げることができ、これらの剤型は、従来から知られている通常の製剤方法で調製することができる。例えば、医薬品製剤や飲食品製剤の製造上許可される担体、賦形剤、香料、乳化剤、防腐剤、分散剤等と混合して成型することができる。上記賦形剤の例としては、ラクトース、デキストロース、セルロース、メチルセルロース、澱粉、水、精製水、アルコール、グリセリン等を挙げることができる。これら製剤は通常経口的に投与される。また、必要に応じてさらに他の有効成分を配合することもできる。 Examples of the dosage form of the SOD gene expression promoter of the present invention and the above preventive / therapeutic agents, supplements, food additives, or feed additives include powders, tablets, capsules, granules, powders, liquids, and the like. These dosage forms can be prepared by conventional formulation methods conventionally known. For example, it can be molded by mixing with carriers, excipients, fragrances, emulsifiers, preservatives, dispersants and the like that are permitted in the manufacture of pharmaceutical preparations and food and beverage preparations. Examples of the excipient include lactose, dextrose, cellulose, methylcellulose, starch, water, purified water, alcohol, glycerin and the like. These preparations are usually administered orally. Moreover, another active ingredient can also be mix | blended as needed.
以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこれらの例示に限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, the technical scope of this invention is not limited to these illustrations.
[大麦若葉]
刈り取った大麦若葉10kgを圧搾し、得られた搾汁8kgをスプレードライにより乾燥、粉末化し、大麦若葉搾汁粉末0.5kgを得た。この粉末をM9緩衝液に懸濁し、0.45μmフィルターを通しろ過滅菌し、評価サンプルとした。なお、評価サンプル作製には、グリーンバイオアクティブ株式会社の製法(http://green-gbc.co.jp/technology/)及び特許第4600853号を参考にして行った。
[Barley young leaves]
10 kg of barley young leaves cut out were squeezed, and 8 kg of the resulting juice was dried and powdered by spray drying to obtain 0.5 kg of barley young leaf juice powder. This powder was suspended in M9 buffer, sterilized by filtration through a 0.45 μm filter, and used as an evaluation sample. The evaluation sample was prepared with reference to the production method of Green Bioactive Co., Ltd. (http://green-gbc.co.jp/technology/) and Japanese Patent No. 4600853.
[培地及び緩衝液]
1)M9緩衝液組成(1L当たり)
Na2HPO4 60g、KH2PO4 30g、NaCl 50g、1M MgSO4 1ml、2%ゼラチン 10mlをイオン交換水1Lに溶かし、121℃、20分間滅菌した。
2)S−Basal緩衝液組成(1L当たり)
NaCl 5.84g、KH2PO4 6.81gを、イオン交換水1Lに溶解し、121℃、20分間滅菌した。液温が60℃程度になるまで放冷し、コレステロール/エタノール(5mg/ml)を1ml加えた。
3)S−液体培地(1L当たり)
S−Basal緩衝液 1Lに、1M KH2PO4(pH6.0)10ml、1M CaCl2 3ml、1M MgSO4 3ml、Trace metal solution 10mlを加えた。(全て滅菌済みのものを使用)
4)Trace metal solution組成(1L当たり)
EDTA・2Na 1.86g、FeSO4・7H2O 0.69g、MnCl2・4H2O 0.20g、ZnSO4・7H2O 0.29g、CuSO4・5H2O 0.025gをイオン交換水1Lに溶かし、121℃、20分間滅菌した。
[Medium and buffer]
1) M9 buffer composition (per liter)
Na 2 HPO 4 60 g, KH 2 PO 4 30 g, NaCl 50 g, 1M MgSO 4 1 ml, 2% gelatin 10 ml were dissolved in 1 L of ion-exchanged water and sterilized at 121 ° C. for 20 minutes.
2) S-Basal buffer composition (per liter)
5.84 g of NaCl and 6.81 g of KH 2 PO 4 were dissolved in 1 L of ion exchange water and sterilized at 121 ° C. for 20 minutes. The solution was allowed to cool to about 60 ° C., and 1 ml of cholesterol / ethanol (5 mg / ml) was added.
3) S-liquid medium (per liter)
To 1 L of S-Basal buffer, 10 ml of 1M KH 2 PO 4 (pH 6.0), 3 ml of 1M CaCl 2, 3 ml of 1M MgSO 4 and 10 ml of Trace metal solution were added. (Use all sterilized ones)
4) Trace metal solution composition (per liter)
EDTA · 2Na 1.86 g, FeSO 4 · 7H 2 O 0.69 g, MnCl 2 · 4H 2 O 0.20 g, ZnSO 4 · 7H 2 O 0.29 g, CuSO 4 · 5H 2 O 0.025 g Dissolved in 1 L and sterilized at 121 ° C. for 20 minutes.
[SODの遺伝子発現解析]
ヒト正常繊維芽細胞(Neonatal Normal Human Dermal Fibroblasts:NHDF)を用いて、SODの遺伝子発現解析を行った。ロンザジャパン株式会社より購入したNHDFを、牛胎児血清を10%含有するダルベッコ最小培地(DMEM)で2代継代し、ワーキングセルバンクを調製し、更に1代継代し、実験用として用いた。NHDFをセミコンフルエントまで培養し、1%の大麦若葉搾汁粉末を含む上記培地に交換した。実験コントロールには培地のみを用いた。その後37℃インキュベータ内で48時間培養を行った。
[SOD gene expression analysis]
Gene expression analysis of SOD was performed using human normal fibroblasts (NHDF). NHDF purchased from Lonza Japan Co., Ltd. was passaged 2 times with Dulbecco's minimal medium (DMEM) containing 10% fetal bovine serum, a working cell bank was prepared, and passage 1 was further used for experiments. NHDF was cultured to semi-confluent and replaced with the above medium containing 1% barley squeezed powder. Only medium was used for experimental control. Thereafter, the cells were cultured for 48 hours in a 37 ° C. incubator.
培養が終了した細胞をセルスクレイパーを用いて回収し、遺伝子発現解析用サンプルとした。遺伝子発現解析用サンプルからのtotal RNAの抽出は、QIAGEN RNeasy Midi Kitを用いて行った。抽出したtotal RNAをエタノール沈殿し、遠心分離(12,000rpm、30分)を行った。ピペットで上清を除去し、更に完全にエタノールを除くために、室温で風乾した。その後、100μlのRNase Free waterでtotal RNAを溶解し、水で10倍希釈を行ってから、260nmの吸光度を測定し、吸光度から、total RNA量の計算を行った。計算値から、1μg/μlとなるようにtotal RNA濃度を調整した。total RNAからcDNAを合成するため、滅菌済みマイクロチューブにtotal RNA溶液5μl(total RNA重量として5μg)、Oligo(dT)12−18プライマー1μl(0.5μl/ml)及び、10mM dNTP mix 1μl、RNase Free Waterを6μl加えタッピングし、よく混合した。65℃に設定した湯浴で5分加温後、氷上に1分間放置した。5×First Strand Buffer 4μl、0.1M DTT 1μlを加え混合し、Superscript(R)III Reverse Transcriptase 1μlを加え50℃で1時間酵素反応させた。その後、70℃に設定した湯浴で15分加温し、酵素反応を停止した。溶液が冷却したことを確認し、エタノール沈殿を行った。遠心分離後上清を捨て、真空乾燥機にて残ったエタノールを完全に揮発させ、精製cDNAを得た。精製cDNAを滅菌水で溶解し260nmの吸光度を測定した。吸光度の値から算出したcDNA量から、定量RT−PCR時の検量線として、0.0001μg/μl、0.001μg/μl、0.01μg/μl、0.1μg/μlとなるように濃度調整を行い、サンプルは0.01μg/μlとなるように調整した。定量RT−PCR用96穴プレート1穴当たり、上記濃度のcDNA 10μl、SYBR Green 12.5μl、プライマー(L)(配列:(SOD−1)TGGCCGATGTGTCTATTGAA、(SOD−2)TTGGCCAAGGGAGATGTTAC)0.1μl、プライマー(R)(配列:(SOD−1)AACGACTTCCAGCGTTTCCT、(SOD−2)AGTCACGTTTGATGGCTTCC)0.1μl、滅菌水2.3μlを添加した。定量RT−PCR条件は表1の条件で行った。なお、内部標準として、mRNAの増幅するためのプライマーであるGAP−DHのプライマー(L)配列:GTCAGTGGTGGACCTGACCT及びプライマー(R)配列:TGCTGTAGCCAAATTCGTTGを用いた。 The cultured cells were collected using a cell scraper and used as a gene expression analysis sample. Extraction of total RNA from the gene expression analysis sample was performed using the QIAGEN RNeasy Midi Kit. The extracted total RNA was ethanol precipitated and centrifuged (12,000 rpm, 30 minutes). The supernatant was removed with a pipette and air-dried at room temperature to completely remove ethanol. Thereafter, total RNA was dissolved in 100 μl of RNase Free water, diluted 10-fold with water, absorbance at 260 nm was measured, and the amount of total RNA was calculated from the absorbance. From the calculated value, the total RNA concentration was adjusted to 1 μg / μl. In order to synthesize cDNA from total RNA, 5 μl of total RNA solution (5 μg as total RNA weight), 1 μl of Oligo (dT) 12-18 primer (0.5 μl / ml), 1 μl of 10 mM dNTP mix, RNase 6 μl of Free Water was added and tapped and mixed well. The mixture was heated in a hot water bath set at 65 ° C. for 5 minutes and then left on ice for 1 minute. 4 μl of 5 × First Strand Buffer and 1 μl of 0.1M DTT were added and mixed, 1 μl of Superscript® III Reverse Transcriptase was added, and the mixture was reacted at 50 ° C. for 1 hour. Then, the enzyme reaction was stopped by heating for 15 minutes in a hot water bath set at 70 ° C. After confirming that the solution was cooled, ethanol precipitation was performed. After centrifugation, the supernatant was discarded, and the remaining ethanol was completely volatilized in a vacuum dryer to obtain purified cDNA. The purified cDNA was dissolved in sterilized water and the absorbance at 260 nm was measured. Adjust the concentration from the amount of cDNA calculated from the absorbance value so that the calibration curve during quantitative RT-PCR is 0.0001 μg / μl, 0.001 μg / μl, 0.01 μg / μl, and 0.1 μg / μl. The sample was adjusted to 0.01 μg / μl. Per well of 96-well plate for quantitative RT-PCR, 10 μl of cDNA at the above concentration, 12.5 μl of SYBR Green, primer (L) (sequence: (SOD-1) TGGCCGATGTGTCTATTGAA, (SOD-2) TTGGCCAAGGGAGATGTTAC) 0.1 μl, primer (R) (Sequence: (SOD-1) AACGACTTCCAGCGTTTCCT, (SOD-2) AGTCACGTTTGATGGCTTCC) 0.1 μl, and sterile water 2.3 μl were added. The quantitative RT-PCR conditions were as shown in Table 1. In addition, GAP-DH primer (L) sequence: GTCAGTGGTGGACCTGACCT and primer (R) sequence: TGCTGTAGCCAAATTCGTTG, which are primers for amplifying mRNA, were used as internal standards.
遺伝子発現解析の結果、大麦若葉を添加した細胞ではSOD1及びSOD2のmRNAの発現量が上昇した(図1)。 As a result of gene expression analysis, SOD1 and SOD2 mRNA expression levels increased in cells to which barley young leaves were added (FIG. 1).
[大麦若葉よる寿命延長効果]
1%の大麦若葉搾汁粉末を懸濁したM9緩衝液を、0.45μmフィルターを用いてろ過滅菌し、評価サンプルとした。
[Life extension effect by young barley leaves]
An M9 buffer solution in which 1% of barley young leaf juice powder was suspended was sterilized by filtration using a 0.45 μm filter, and used as an evaluation sample.
S−液体培地に、Escherichia coli OP50株(以後OP50)を、OD660の値が0.9となるように添加、調製した。この培地に、1ml程度のC.elegans溶液を加え、20℃のインキュベーター内で4日間培養して、C.elegansの培養物を得た。 Escherichia coli OP50 strain (hereinafter referred to as OP50) was added and prepared in an S-liquid medium so that the value of OD 660 was 0.9. About 1 ml of C. elegans solution was added to this medium and cultured in an incubator at 20 ° C. for 4 days to obtain a C. elegans culture.
C.elegansの世代を統一するために、同調培養を行った。具体的には、C.elegansを上記培養方法にて大量飼育し、S−液体培地から卵を抱えたC.elegansを回収し、15ml遠心管に移した。5〜10分間静置し、C.elegansを沈殿させ、上清を除去した。新たにM9緩衝液を1ml加え軽くピペッティングし、1.5mlマイクロチューブに移した。5分間静置し、C.elegansを沈殿させ、上清を除去した。新たにM9緩衝液を1ml加え、更に266μlの次亜塩素酸ナトリウム、133μlのNaOHを加え、室温で激しく転倒混合し、C.elegansの身体を溶解させ、卵を回収した。その後、800×gで5分間遠心分離し、卵を沈殿させた。上清を捨て1.4mlのM9緩衝液を加え、800×gで5分間遠心分離した。この操作を5回繰り返し、卵の洗浄を行った。上清を捨て回収した卵に新たに1mlのS−basal緩衝液を加え、ピペットマンを用いて、OP50を含まないS−液体培地10mlに添加し、20℃で一晩培養して、孵化させた。孵化を確認したら、OP50を含むS−液体培地を10ml加え、更に24時間20℃のインキュベーターで培養した。 In order to unify the generation of C. elegans, synchronized culture was performed. Specifically, C. elegans was bred in large quantities by the above culture method, and C. elegans carrying eggs were collected from the S-liquid medium and transferred to a 15 ml centrifuge tube. The mixture was allowed to stand for 5 to 10 minutes to precipitate C. elegans, and the supernatant was removed. 1 ml of M9 buffer solution was newly added and lightly pipetted and transferred to a 1.5 ml microtube. The mixture was allowed to stand for 5 minutes to precipitate C. elegans, and the supernatant was removed. 1 ml of M9 buffer was newly added, and 266 μl of sodium hypochlorite and 133 μl of NaOH were further added. The mixture was vigorously inverted at room temperature to dissolve the body of C. elegans, and the eggs were collected. Thereafter, the mixture was centrifuged at 800 × g for 5 minutes to precipitate the eggs. The supernatant was discarded and 1.4 ml of M9 buffer was added and centrifuged at 800 × g for 5 minutes. This operation was repeated 5 times to wash the eggs. 1 ml of S-basal buffer was newly added to the recovered eggs after discarding the supernatant, and added to 10 ml of S-liquid medium not containing OP50 using Pipetman, and cultured overnight at 20 ° C. to hatch. . When hatching was confirmed, 10 ml of S-liquid medium containing OP50 was added and further cultured in an incubator at 20 ° C. for 24 hours.
線虫生存率の測定を行った。一般的な蓋付き平底6ウェルプレートを用意し、同調培養後の孵化したC.elegansを1ウェルあたり30匹加えこれをn=1とした。実験の再現性を高める為、1群当たり3ウェルを用いてn=3とした。使用した培地はS−液体培地にOP50と5−フルオロ−2′−デオキシウリジン(終濃度0.04mM)、評価サンプルを添加したものを使用し、以後、マイクロピペットを用いて一日おきに、生存しているC.elegansの数をカウントしながら、新たに調製したS−液体培地の入ったウェルへ移動した。培養初日の生存C.elegans数30匹から、培養日数ごとに何割のC.elegansが生存し続けているかを計算し線虫生存率とした。なお、5−フルオロ−2′−デオキシウリジンは、DNA合成阻害剤であり、寿命試験中に次世代のC.elegansが混入し正確な生存率を求めることができなくならないように、培養最終日まで加え続けた。 The nematode survival rate was measured. A general flat-bottomed 6-well plate with a lid was prepared, 30 hatched C. elegans after synchronous culture were added per well, and this was set to n = 1. To increase the reproducibility of the experiment, n = 3 using 3 wells per group. The medium used was an S-liquid medium supplemented with OP50, 5-fluoro-2'-deoxyuridine (final concentration 0.04 mM), and an evaluation sample. Thereafter, every other day using a micropipette, While counting the number of surviving C. elegans, the cells were transferred to wells containing freshly prepared S-liquid medium. The number of C. elegans surviving on the first day of culture was calculated from the number of 30 C. elegans per day, and the percentage of C. elegans continued to survive was calculated as the nematode survival rate. In addition, 5-fluoro-2'-deoxyuridine is a DNA synthesis inhibitor, so that the next day of C. elegans is not mixed during the life test and the accurate survival rate cannot be obtained. Continued to add.
線虫生存率の測定を行った結果、コントロールに比べ大麦若葉の搾汁粉末を投与した群において寿命延長効果が確認された(図2)。生存率が10%になるまでの日数を比較しても、図2同様、コントロールに比べ大麦若葉の搾汁粉末を投与した群において有意な寿命延長効果が確認された(図3)。 As a result of measuring the nematode survival rate, the life extension effect was confirmed in the group to which the barley young leaf squeezed powder was administered compared to the control (FIG. 2). Even when the number of days until the survival rate reached 10% was compared, as in FIG. 2, a significant life extension effect was confirmed in the group administered with barley young leaf squeezed powder as compared to the control (FIG. 3).
すなわち、本発明は、大麦若葉を有効成分として含有し、体内のSOD発現量を上昇させることを特徴とするSODの遺伝子発現促進剤に関する。
That is, the present invention provides a barley young leaves contain as an active ingredient, about the gene expression promoter of SOD, characterized in that to increase the SOD expression levels in the body.
すなわち、本発明は、大麦若葉を有効成分として含有し、哺乳類体内の哺乳類SOD発現量を上昇させることを特徴とする哺乳類SODの遺伝子発現促進剤に関する。
That is, the present invention relates to a mammalian SOD gene expression promoter characterized by containing young barley leaves as an active ingredient and increasing the mammalian SOD expression level in the mammalian body.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014015776A JP5958865B2 (en) | 2014-01-30 | 2014-01-30 | Anti-aging related gene expression promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014015776A JP5958865B2 (en) | 2014-01-30 | 2014-01-30 | Anti-aging related gene expression promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015140338A true JP2015140338A (en) | 2015-08-03 |
JP5958865B2 JP5958865B2 (en) | 2016-08-02 |
Family
ID=53770935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014015776A Active JP5958865B2 (en) | 2014-01-30 | 2014-01-30 | Anti-aging related gene expression promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5958865B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004194616A (en) * | 2002-12-20 | 2004-07-15 | Creatis Dam:Kk | Health food product containing young barley leaf powder extract and fresh water clam extract |
JP2004304735A (en) * | 2003-04-01 | 2004-10-28 | Sony Corp | Photographing apparatus and camera-shake correction method |
JP2006321735A (en) * | 2005-05-18 | 2006-11-30 | Creatis Dam:Kk | Prevention of lipid peroxide by active oxygen-removing enzyme of sod contained in barley young leaf extract powder |
-
2014
- 2014-01-30 JP JP2014015776A patent/JP5958865B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004194616A (en) * | 2002-12-20 | 2004-07-15 | Creatis Dam:Kk | Health food product containing young barley leaf powder extract and fresh water clam extract |
JP2004304735A (en) * | 2003-04-01 | 2004-10-28 | Sony Corp | Photographing apparatus and camera-shake correction method |
JP2006321735A (en) * | 2005-05-18 | 2006-11-30 | Creatis Dam:Kk | Prevention of lipid peroxide by active oxygen-removing enzyme of sod contained in barley young leaf extract powder |
Non-Patent Citations (4)
Title |
---|
JPN6014028642; 白土直 他: '大麦若葉配合健康食品「健香菜美」の各種作用' 日本薬学会年会要旨集 Vol.125th,No.4, 2005, Page.182 * |
JPN6014028645; 古賀良太 他: '健常人を対象とした大麦若葉末の抗酸化作用について' 日本未病システム学会雑誌 Vol.19,No.1, 2013, Page.10-18 * |
JPN6014028647; 西山直志 他: '大麦若葉の青汁成分の研究 (第38報) 抗酸化活性成分による生体過酸化の抑制 (3)' 日本薬学会年会要旨集 Vol.115th,No.Pt 2, 1995, Page.224 * |
JPN6014028649; 戸田年総: 'タンパク質の酸化修飾と老化' 基礎老化研究 Vol.35,No.3, 2011, Page.17-22 * |
Also Published As
Publication number | Publication date |
---|---|
JP5958865B2 (en) | 2016-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3231437B1 (en) | Aging inhibitor | |
CN102292093B (en) | Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome | |
KR100803998B1 (en) | Fermented extract of Citrus Sunkii Hort, Method for processing thereof, and the healthy and funtional foods | |
WO2015190872A1 (en) | Pharmaceutical composition containing spirulina maxima extract as active ingredient for treating and preventing obesity | |
JP2010105937A (en) | Glutathione production promoting composition | |
CN114272356A (en) | Formula and preparation method of anti-aging pharmaceutical composition | |
JP5958865B2 (en) | Anti-aging related gene expression promoter | |
KR20220110443A (en) | Composition for preventing or treating of muscle disease or improvement of muscular functions comprising Rhododendron brachycarpum extract, Codonopsis Pilosulae Radix extract, or Sophora flavescens extract, or active component separated therefrom as an active ingredient | |
KR102472951B1 (en) | A composition for immune enhancement comprising narrow-leaf erecta fig extract mixture | |
CN107836712A (en) | Natural extract composition, preparation and application with antioxidation | |
WO2016206363A1 (en) | Use of jilin ginseng oligopeptide in preparation of anti-oxidant food product or health care food product | |
KR101672098B1 (en) | Composition for removing hangover comprising fermented rice rinse water | |
KR101385191B1 (en) | Use of Cichorium intybus extracts for preventing, treating improving muscular atrophy | |
WO2016072507A1 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR | |
KR20180079920A (en) | Composition for preventing, improving or treating hepatic fibrosis or liver cirrhosis comprising Cuscuta Semen extract | |
KR101881016B1 (en) | Composition for lifespan extension containing eggplant extract | |
US8367060B2 (en) | Pharmaceutical composition containing arazyme for the prevention of liver dysfunction | |
KR102241169B1 (en) | Composition for prevention, improvement or treatment of liver fibrosis or cirrhosis including Allium senescens L. Extract | |
JP2020186215A (en) | Composition for improvement of menopause symptom | |
JP6513404B2 (en) | Fat burning promoter and hypothermia improving agent | |
KR102556835B1 (en) | Composition comprising extract of Heracleum moellendorffii for immune-enhancement and anti-obesity | |
JP2013253031A (en) | Anti-aging related gene transcription promotor | |
KR20140093330A (en) | A composition for preventing or treating blood vessel disorders, comprising extracts of Acanthopanax | |
KR102626559B1 (en) | Composition comprising extract of Hibiscus manihot for immune-enhancement | |
TW201132291A (en) | Immunostimulant having allium-derived component, method for producing immunostimulant, food composition, and immunostimulatory method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150106 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160610 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5958865 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |